A naturally occurring compound called ibogaine, derived from the iboga tree in Central Africa, has shown promise in treating opioid addiction. Studies suggest that a significant number of patients achieve sobriety after a single session of ibogaine treatment. Researchers are also exploring its potential in treating traumatic brain injuries and PTSD. Ibogaine is classified as a Schedule I controlled substance in the United States, similar to heroin. Americans seeking ibogaine therapy must travel to countries where it is legal or unregulated.
